Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. TG United, Inc.
WARNING LETTER
•TG United, Inc.•February 15, 2019

TG United, Inc. – FDA Warning Letter, Feb 15, 2019

Record Details

The FDA inspected TG United, Inc.'s drug manufacturing facility from December 17, 2018, to February 15, 2019, identifying significant Current Good Manufacturing Practice (CGMP) violations, rendering their drug products adulterated. Additionally, the firm manufactures and markets ten unapproved new drugs, including HISTEX PD Drops and Rynex DM, which violate section 505(a) of the FD&C Act because their labeling for children under six years of age does not comply with the OTC cough/cold final rule (21 CFR 341). CGMP deficiencies include a failure to thoroughly investigate unexplained discrepancies, out-of-specification (OOS) results, and water system monitoring failures (21 CFR 211.192). The firm also failed to ensure equipment, specifically the (b)(4) water systems, was of appropriate design and adequately controlled (21 CFR 211.63), and failed to adequately clean and maintain shared equipment (21 CFR 211.67(a)). Furthermore, the stability testing program was inadequate, lacking validated test methods for impurities (21 CFR 211.166(a)). Many of these CGMP violations are repeat observations from prior inspections dating back to 2010, indicating a systemic lack of executive management oversight. The FDA strongly recommends engaging a qualified CGMP consultant. The firm must respond within 15 working days with corrective actions and a timeline, or face potential legal action, including seizure, injunction, and impact on drug approvals and export certificates.

Company
TG United, Inc.
Inspection date
February 15, 2019
Product type
Drugs
Office
Office of Pharmaceutical Quality Operations Division I
Person
  • Monica R. Maxwell (Program Division Director)
View Company Profile

ID · f906e2de-145a-4951-91a5-9a2805e10f23

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121.U.S.C. 355(a)21 U.S.C. 331(d)21 CFR 211.19221 CFR 211.6321 CFR 211.67(a)21 CFR 211.166(a)21 U.S.C. 321(g)(1)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore TG United, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.